Hims & Hers Health Inc
(NYSE:HIMS)
$
20.05
-0.71 (-3.42%)
Market Cap: 4.34 Bil
Enterprise Value: 4.12 Bil
PE Ratio: 250.63
PB Ratio: 12.01
GF Score: 54/100 Hims & Hers Health Inc at Citi Healthcare Conference (Virtual) Transcript
Feb 24, 2022 / 08:30PM GMT
Release Date Price:
$5.01
(+5.47%)
Daniel R. Grosslight
Citigroup Inc., Research Division - Research Analyst
All right. Good afternoon, everyone, and thank you for joining the Hims & Hers Presentation here at the Citi Healthcare Services Conference. This is the last presentation of the conference, and we're saving the best for last, right, Andrew and Yemi?
We've got the management team here, Andrew Dudum, the CEO of Hims; Yemi Okupe, the brand-new CFO of Hims & Hers. Welcome, guys. Thanks for joining us here today.
Andrew Dudum
Hims & Hers Health, Inc. - Co-Founder, Director & CEO
Thanks for having us.
Questions & Answers
Daniel R. Grosslight
Citigroup Inc., Research Division - Research Analyst
Maybe we'll just jump right in with the key controversy here, and it's one that I get asked all the time. It's around barriers to entry, competition, et cetera.
So I'd love to get your thoughts on the moat here. We've seen a proliferation of well-funded DTC virtual health companies come to the market. They're
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot